Frankfurt - Delayed Quote EUR

Tristel plc (R1V.F)

4.6200
-0.2200
(-4.55%)
At close: May 14 at 9:39:12 PM GMT+2
Loading Chart for R1V.F
  • Previous Close 4.8400
  • Open 4.8400
  • Bid 4.6200 x --
  • Ask 4.8600 x --
  • Day's Range 4.6200 - 4.8400
  • 52 Week Range 3.0400 - 5.9000
  • Volume 120
  • Avg. Volume 52
  • Market Cap (intraday) 223.067M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) 30.80
  • EPS (TTM) 0.1500
  • Earnings Date Feb 24, 2025
  • Forward Dividend & Yield 0.17 (3.43%)
  • Ex-Dividend Date Mar 20, 2025
  • 1y Target Est --

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

tristel.com

233

Full Time Employees

June 30

Fiscal Year Ends

Recent News: R1V.F

View More

Performance Overview: R1V.F

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

R1V.F
5.90%
FTSE 100 (^FTSE)
5.04%

1-Year Return

R1V.F
4.76%
FTSE 100 (^FTSE)
1.86%

3-Year Return

R1V.F
33.53%
FTSE 100 (^FTSE)
15.73%

5-Year Return

R1V.F
1.32%
FTSE 100 (^FTSE)
49.53%

Compare To: R1V.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: R1V.F

View More

Valuation Measures

Annual
As of 5/13/2025
  • Market Cap

    235.08M

  • Enterprise Value

    228.21M

  • Trailing P/E

    31.60

  • Forward P/E

    20.79

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.45

  • Price/Book (mrq)

    6.18

  • Enterprise Value/Revenue

    4.41

  • Enterprise Value/EBITDA

    18.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.09%

  • Return on Assets (ttm)

    12.40%

  • Return on Equity (ttm)

    19.61%

  • Revenue (ttm)

    43.56M

  • Net Income Avi to Common (ttm)

    6.14M

  • Diluted EPS (ttm)

    0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.74M

  • Total Debt/Equity (mrq)

    18.93%

  • Levered Free Cash Flow (ttm)

    6.55M

Research Analysis: R1V.F

View More

Company Insights: R1V.F

Research Reports: R1V.F

View More

People Also Watch